Outcome of Board Meeting dated 28 May 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250 and 6.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with an unmodified (clean) auditor opinion from S S Kothari Mehta & Co. LLP. Standalone revenue from continuing operations grew to Rs 2,234.06 lakhs (vs Rs 1,447.13 lakhs restated in FY24). However, the company reported a massive standalone loss after tax of Rs (36,634) lakhs for FY25 (vs a profit of Rs 4,629 lakhs in FY24), driven almost entirely by a one-time exceptional loss of Rs (37,494) lakhs arising from the demerger of its Insoluble Sulphur & Chemicals manufacturing business into OCCL Limited (effective July 1, 2024), treated as discontinued operations under Ind AS 105. Operating cash flow remained positive at Rs 628 lakhs. The board also approved voluntary delisting from NSE, appointed a new additional director (Mrs. Mitali Gupta), re-appointed internal auditor, appointed a new secretarial auditor, and approved shifting the registered office from Gujarat to another state.
The headline loss is a non-cash, one-time accounting effect from the demerger and does not reflect ongoing business health — continuing operations remain profitable (PBT of Rs 487.56 lakhs). Shareholders should note the voluntary delisting from NSE, which may reduce liquidity for those trading on NSE, and the proposed registered office shift.